Atypical antipsychotics in the treatment of schizophrenia during pregnancy and the postpartum.
Yaeger
Deborah
D
Department of Psychiatry, VA Greater Los Angeles Healthcare System, West Los Angeles Healthcare Center, CA 90073, USA. Deborah.Yaeger@va.gov
Smith
Healy G
HG
Altshuler
Lori L
LL
D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D003987:Dibenzothiazepines / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007237:Infanticide / Q000517:prevention & control / Q000523:psychology; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy* / Q000523:psychology; D011618:Psychotic Disorders / Q000188:drug therapy / Q000523:psychology; D011644:Puerperal Disorders / Q000188:drug therapy* / Q000523:psychology; D000069348:Quetiapine Fumarate; D018570:Risk Assessment; D012307:Risk Factors; D012559:Schizophrenia / Q000175:diagnosis / Q000188:drug therapy*; D012565:Schizophrenic Psychology; D055502:Secondary Prevention; D012944:Social Support
D014150:Antipsychotic Agents; D003987:Dibenzothiazepines; D000069348:Quetiapine Fumarate